GSMA
24.1.2019 06:02:12 CET | Business Wire | Press release
The GSMA today launched the ‘Digital Declaration’ at the World Economic Forum in Davos. The declaration captures key principles that serve as a guide to acting ethically in the digital era, helping companies deliver what matters most to digital citizens, industry and governments. The 40 business leaders who have already committed to the declaration span several industry sectors and include representatives from: Bharti Airtel, China Mobile, China Telecom, Deutsche Telekom, Ericsson, IBM, KDDI, KT, LG Electronics, Mobile World Capital Barcelona, Nokia, NTT DOCOMO, Orange, Samsung Electronics, Sharp, SK Telecom, Sony Corporation, STC Group, Telefónica, Turkcell, Verizon, Vodafone and Xiaomi.
The initiative has arisen against a backdrop of businesses and consumers experiencing unprecedented change in the digital world. It is expected that by 2022, 60 per cent of GDP will be digitised1 . The imminent arrival of 5G networks will further accelerate this change. At the same time consumers are rightfully expecting more from digital services, while their trust in businesses is being tested.
The Digital Declaration is a cross-industry movement of CEOs confronting these shared challenges. Its principles call on businesses to; respect the privacy of digital citizens; handle personal data securely and transparently; take meaningful steps to mitigate cyber threats; and ensure everyone can participate in the digital economy as it develops whilst combatting online harassment. Taken together, these commitments will ensure the internet is kept as an open platform for expression and a driver of innovation.
“Social, technological, political and economic currents are combining to create a perfect storm of disruption across all industries,” said Mats Granryd, Director General GSMA. “A new form of responsible leadership is needed to successfully navigate this era. We are on the cusp of the 5G era, which will spark exciting new possibilities for consumers and promises to transform the shape of virtually every business. In the face of this disruption, those that embrace the principles of the Digital Declaration will strive for business success in ways that seek a better future for their consumers and societies. Those that do not change can expect to suffer increasing scrutiny from shareholders, regulators and consumers.”
“A positive and enabling digital future is integral to a truly empowered and inclusive society,” said Sunil Bharti Mittal, Chairman of Bharti Airtel – the first business leader to sign the Digital Declaration. “Such a future can only be built through constructive collaboration and continuous dialogue among key stakeholders. It is imperative for industry to make the required investments to build a sustainable digital ecosystem and maintain citizen’s trust through transparent and responsible conduct with regard to privacy and data.”
“Backing The Digital Declaration fits into our vision to enable a progressive, free and enlightened society,” said Stéphane Richard, Chairman and Chief Executive Officer of Orange, and Chair of the GSMA. “Orange fights digital exclusion with innovations that are accessible to the greatest possible number of people. We secure and facilitate our customers’ digital lives thanks to our expertise in cybersecurity and in digital identity. Joining the Digital Declaration provides us with a shared vision of acting responsibly as we help our customers enter the eras of artificial intelligence and of the internet of things.”
Mobile is one of the most widely deployed technology platforms ever with more than 5 billion unique mobile subscribers worldwide, representing approximately two-thirds of the world’s population – forecast to grow to almost 6 billion (71 per cent) by 2025. Representing the mobile industry globally, the GSMA is at the heart of many of the technological innovations already shaping tomorrow’s digital society, including 5G. The industry body has worked with business leaders to shape the declaration to demonstrate the private sector’s commitment to responsible leadership at a time when policymakers are facing new challenges from the evolving digital ecosystem.
As we move into an era of Intelligent Connectivity, the combination of endless connectivity enabled through 5G and the Internet of Things, with the powerful intelligence delivered by big data and artificial intelligence will further transform entire industries. Through embracing the Digital Declaration, CEOs are showing their commitment to acting responsibly as they keep pace with this rapid rate of technology change.
The GSMA is inviting business leaders from any sector to join the Digital Declaration and ask themselves what role they can play in creating a better digital society. Further information on the Digital Declaration, including details of CEOs that have already joined can be found here .
-ENDS-
Notes to Editors
1. World Economic Forum, ‘Our Shared Digital Future’ Report (Dec 2018)
About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators with over 350 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces the industry-leading MWC events held annually in Barcelona, Los Angeles and Shanghai, as well as the Mobile 360 Series of regional conferences.
For more information, please visit the GSMA corporate website at www.gsma.com . Follow the GSMA on Twitter: @GSMA .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190123005491/en/
Contact:
Media Contacts: For the GSMA Alia Ilyas +44 (0)7970 637622 ailyas@gsma.com GSMA Press Office pressoffice@gsma.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
